Skip to Content

Farxiga FDA Approval History

Reviewed by Judith Stewart BPharm. Last updated on May 6, 2020.

FDA Approved: Yes (First approved January 8, 2014)
Brand name: Farxiga
Generic name: dapagliflozin
Dosage form: Tablets
Company: AstraZeneca
Treatment for: Diabetes, Type 2

Farxiga (dapagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for the treatment of type 2 diabetes mellitus and heart failure.